The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics-Reference-Cited by-同舟云学术

The 2012 BSR and BHPR guideline for the treatment of psoriatic arthritis with biologics

Published:2013-07-23 Issue:10 Volume:52 Page:1754-1757
ISSN:1462-0332
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Coates Laura C.,Tillett William,Chandler David,Helliwell Philip S.,Korendowych Eleanor,Kyle Stuart,McInnes Iain B.,Oliver Susan,Ormerod Anthony,Smith Catherine,Symmons Deborah,Waldron Nicola,McHugh Neil J.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/52/10/1754/17706157/ket187.pdf

Reference2 articles.

1. British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009;Smith;Br J Dermatol,2009

2. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis;Braun;Ann Rheum Dis,2011

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Saudi consensus recommendations for the management of psoriatic arthritis (2023);Clinical Rheumatology;2024-01-13

2. Switching related to inefficacy in biologics and targeted synthetic therapies for psoriatic arthritis: a comparative real-life study;Therapeutic Advances in Musculoskeletal Disease;2024-01

3. Early psoriatic arthritis: when is the right time to start advanced therapy?;Therapeutic Advances in Musculoskeletal Disease;2024-01

4. An overview of psoriatic arthritis including clinical manifestations, assessment, diagnostic criteria, investigations, drug management and GRAPPA guidelines;Musculoskeletal Care;2022-11

5. Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs;Rheumatology;2022-05-31